Details for New Drug Application (NDA): 020507
✉ Email this page to a colleague
The generic ingredient in TECZEM is diltiazem malate; enalapril maleate. There are twenty-six drug master file entries for this compound. Additional details are available on the diltiazem malate; enalapril maleate profile page.
Summary for 020507
Tradename: | TECZEM |
Applicant: | Biovail |
Ingredient: | diltiazem malate; enalapril maleate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 180MG HYDROCHLORIDE;5MG | ||||
Approval Date: | Oct 4, 1996 | TE: | RLD: | No |
Expired US Patents for NDA 020507
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Biovail | TECZEM | diltiazem malate; enalapril maleate | TABLET, EXTENDED RELEASE;ORAL | 020507-001 | Oct 4, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Biovail | TECZEM | diltiazem malate; enalapril maleate | TABLET, EXTENDED RELEASE;ORAL | 020507-001 | Oct 4, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Biovail | TECZEM | diltiazem malate; enalapril maleate | TABLET, EXTENDED RELEASE;ORAL | 020507-001 | Oct 4, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription